ConductScience.org, home

85,013 comparisons from ClinicalTrials.gov.

85,013 comparisons

Most participants first33,758 with no events in either group come last2,261 to 2,280 of 85,013

Show the results as
ComparisonWith the outcomeRisk difference, 95% intervalParticipantsTrial
M72AS01 Group vs Control Group: serious adverse events51 of 1,786

62 of 1,787

-0.6 points

-1.8 to 0.5

3,573NCT01755598

Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults

PCI at Hospitals Without On-Site Cardiac Surgery vs PCI at Hospital With On-Site Cardiac Surgery: Any Repeat Revascularization73 of 2,689

31 of 883

-0.8 points

-2.3 to 0.4

3,572NCT01116882

Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings

PCI at Hospitals Without On-Site Cardiac Surgery vs PCI at Hospital With On-Site Cardiac Surgery: Ischemia-driven Target Vessel Revascularization41 of 2,689

13 of 882

0.1 points

-1.1 to 0.9

3,571NCT01116882

Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings

PCI at Hospitals Without On-Site Cardiac Surgery vs PCI at Hospital With On-Site Cardiac Surgery: Ischemia-driven Target Lesion Revascularization36 of 2,689

12 of 882

-0.0 points

-1.1 to 0.8

3,571NCT01116882

Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings

PCI at Hospitals Without On-Site Cardiac Surgery vs PCI at Hospital With On-Site Cardiac Surgery: Major Vascular Complications41 of 2,687

13 of 882

0.1 points

-1.1 to 0.9

3,569NCT01116882

Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings

Intervention Group vs Control Group: Number of Patients With Elevated Blood Pressures Measured and Recognized by Provider1,394 of 1,834

1,013 of 1,728

17.4 points

14.3 to 20.4

3,562NCT02798354

Reducing Diagnostic Errors in Primary Care Pediatrics (Project RedDE)

Intervention Group vs Control Group: Number of Patients With Elevated Blood Pressure Measured and Appropriately Acted on by Providers1,378 of 1,834

969 of 1,728

19.1 points

16.0 to 22.1

3,562NCT02798354

Reducing Diagnostic Errors in Primary Care Pediatrics (Project RedDE)

Intervention Group vs Control Group: Number of Patients With Elevated Blood Pressures Measured and Blood Pressure Percentiles Documented in the Chart1,681 of 1,834

1,233 of 1,728

20.3 points

17.8 to 22.8

3,562NCT02798354

Reducing Diagnostic Errors in Primary Care Pediatrics (Project RedDE)

Sepsis Transition and Recovery (STAR) Program vs Usual Care: Palliative Care Consultation430 of 2,122

234 of 1,426

3.9 points

1.2 to 6.4

3,548NCT04495946

Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship

Sepsis Transition and Recovery (STAR) Program vs Usual Care: All-cause Mortality and Hospital Readmission Rate1,023 of 2,122

684 of 1,426

0.2 points

-3.1 to 3.6

3,548NCT04495946

Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship

Sepsis Transition and Recovery (STAR) Program vs Usual Care: Count of Participants With Support Service Referrals594 of 2,122

374 of 1,426

1.8 points

-1.2 to 4.7

3,548NCT04495946

Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship

Sepsis Transition and Recovery (STAR) Program vs Usual Care: All-cause Hospital Readmission Rate763 of 2,122

478 of 1,426

2.4 points

-0.8 to 5.6

3,548NCT04495946

Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship

Sepsis Transition and Recovery (STAR) Program vs Usual Care: Completed Care Preferences526 of 2,122

309 of 1,426

3.1 points

0.3 to 5.9

3,548NCT04495946

Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship

Sepsis Transition and Recovery (STAR) Program vs Usual Care: Inpatient Mental Health Assessment2,048 of 2,122

1,385 of 1,426

-0.6 points

-1.8 to 0.6

3,548NCT04495946

Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship

Sepsis Transition and Recovery (STAR) Program vs Usual Care: Inpatient Functional Assessment or Physical Therapy Consult1,768 of 2,122

1,196 of 1,426

-0.6 points

-3.0 to 2.0

3,548NCT04495946

Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship

Sepsis Transition and Recovery (STAR) Program vs Usual Care: All-cause Mortality Rate367 of 2,122

292 of 1,426

-3.2 points

-5.9 to -0.6

3,548NCT04495946

Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship

Sepsis Transition and Recovery (STAR) Program vs Usual Care: Outpatient Medication Reconciliation1,590 of 2,122

866 of 1,426

14.2 points

11.1 to 17.3

3,548NCT04495946

Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship

Sepsis Transition and Recovery (STAR) Program vs Usual Care: Early Outpatient Provider Follow up468 of 2,122

348 of 1,426

-2.3 points

-5.2 to 0.5

3,548NCT04495946

Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship

Sepsis Transition and Recovery (STAR) Program vs Usual Care: deaths from any cause367 of 2,122

292 of 1,426

-3.2 points

-5.9 to -0.6

3,548NCT04495946

Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship

Sepsis Transition and Recovery (STAR) Program vs Usual Care: Cause-specific Hospital Readmission Rate370 of 2,122

222 of 1,426

1.9 points

-0.6 to 4.3

3,548NCT04495946

Implementation and Effectiveness of Engagement and Collaborative Management to Proactively Advance Sepsis Survivorship

Request

GET /api/comparisons/v1

Words from a trial's title, conditions or interventions, its outcome or its groups, or an NCT number.

An outcome counted in participants, the serious adverse events, or the deaths from any cause.

No key needed

Code

Show the call in
curl "https://conductscience.org/api/comparisons/v1?page=114"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=114

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT01755598-sae",
        "title": "M72AS01 Group vs Control Group: serious adverse events",
        "summary": "51 of 1786 against 62 of 1787; risk difference -0.6 points, 95% interval -1.8 to 0.5; NCT01755598, Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults",
        "record": "/library/comparisons/NCT01755598-sae",
        "nct_id": "NCT01755598",
        "kind": "serious-adverse-events",
        "participants": 3573,
        "risk_difference": {
          "value": -0.0061395884548791115,
          "lower": -0.017831726796408598,
          "upper": 0.005441857841151643
        },
        "group_1": "51 of 1,786",
        "group_2": "62 of 1,787",
        "difference": "-0.6 points",
        "interval": "-1.8 to 0.5",
        "trial_title": "Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults"
      },
      {
        "id": "NCT01116882-6e3b09e2",
        "title": "PCI at Hospitals Without On-Site Cardiac Surgery vs PCI at Hospital With On-Site Cardiac Surgery: Any Repeat Revascularization",
        "summary": "73 of 2689 against 31 of 883; risk difference -0.8 points, 95% interval -2.3 to 0.4; NCT01116882, Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings",
        "record": "/library/comparisons/NCT01116882-6e3b09e2",
        "nct_id": "NCT01116882",
        "kind": "outcome",
        "participants": 3572,
        "risk_difference": {
          "value": -0.007959949241635844,
          "lower": -0.023275143336832047,
          "upper": 0.004381237276717145
        },
        "group_1": "73 of 2,689",
        "group_2": "31 of 883",
        "difference": "-0.8 points",
        "interval": "-2.3 to 0.4",
        "trial_title": "Percutaneous Coronary Intervention (PCI) Outcomes in Community Versus Tertiary Settings"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=115",
  "request_id": "iEJFyzipSmodBtTE"
}

Ask about these results. The first 10 go in the prompt.

About this data
Holds
85,013 comparisons
From ClinicalTrials.gov. Counted 10 Nov 2026.
Release
23 Mar 2026
trial-comparisons-2026-03-23-0.1.0
Checked
20 of 20 review comparisons traced to ClinicalTrials.gov, and all 510,078 numbers calculated again apart from the builder agree
Access
Open
No account. 60 calls a minute from one address.

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

Genes

NCBI Gene

One gene with its proteins, patents, drugs, trials, grants and papers.

Trials

ClinicalTrials.gov

Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.

Sequences

Patent publications

Paste a sequence and see the patents that disclose it.

Opens sequences.conductscience.org

For software

Read Trial comparisons from software.

Every answer on this page is also JSON, under /api/comparisons/v1. No key.

GET https://conductscience.org/api/comparisons/v1?q=placebo%20heart%20failure&kind=outcome

Ask an assistant

  • In FOURIER, how did serious adverse events compare between evolocumab and placebo?
  • Which metformin trials reported deaths, and what was the risk difference?
  • What was the number needed to treat for HELIOS-B's composite outcome?
  • Which placebo-controlled heart failure trials had the most participants?